Pfizer Korea Country Manager Oh Dong-wook gives an opening speech at a press event regarding the regulatory approval of Pfizer's latest pneumococcal vaccine at Lotte Hotel in central Seoul on Tuesday.

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

Pfizer Prevnar ...